nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CHRM1—Citalopram—alcohol dependence	0.251	0.541	CbGbCtD
Cevimeline—CYP2D6—Citalopram—alcohol dependence	0.0845	0.182	CbGbCtD
Cevimeline—CYP3A4—Disulfiram—alcohol dependence	0.0754	0.162	CbGbCtD
Cevimeline—CYP3A4—Citalopram—alcohol dependence	0.0537	0.116	CbGbCtD
Cevimeline—FMO1—forebrain—alcohol dependence	0.00236	0.0978	CbGeAlD
Cevimeline—FMO1—digestive system—alcohol dependence	0.00166	0.0687	CbGeAlD
Cevimeline—FMO1—endocrine gland—alcohol dependence	0.00137	0.0567	CbGeAlD
Cevimeline—FMO1—nervous system—alcohol dependence	0.00128	0.0531	CbGeAlD
Cevimeline—FMO1—liver—alcohol dependence	0.00123	0.0512	CbGeAlD
Cevimeline—FMO1—central nervous system—alcohol dependence	0.00123	0.0511	CbGeAlD
Cevimeline—CHRM1—forebrain—alcohol dependence	0.00108	0.0449	CbGeAlD
Cevimeline—FMO1—brain—alcohol dependence	0.00098	0.0406	CbGeAlD
Cevimeline—CHRM3—forebrain—alcohol dependence	0.00097	0.0402	CbGeAlD
Cevimeline—CHRM1—cardiovascular system—alcohol dependence	0.000917	0.038	CbGeAlD
Cevimeline—CHRM3—digestive system—alcohol dependence	0.000681	0.0282	CbGeAlD
Cevimeline—CHRM1—endocrine gland—alcohol dependence	0.000629	0.0261	CbGeAlD
Cevimeline—CHRM1—nervous system—alcohol dependence	0.000588	0.0244	CbGeAlD
Cevimeline—CHRM1—central nervous system—alcohol dependence	0.000567	0.0235	CbGeAlD
Cevimeline—CHRM3—endocrine gland—alcohol dependence	0.000563	0.0233	CbGeAlD
Cevimeline—CYP2D6—brainstem—alcohol dependence	0.000543	0.0225	CbGeAlD
Cevimeline—CHRM3—testis—alcohol dependence	0.000537	0.0222	CbGeAlD
Cevimeline—CHRM3—nervous system—alcohol dependence	0.000527	0.0218	CbGeAlD
Cevimeline—CYP2D6—forebrain—alcohol dependence	0.000525	0.0217	CbGeAlD
Cevimeline—CHRM3—central nervous system—alcohol dependence	0.000507	0.021	CbGeAlD
Cevimeline—CHRM1—brain—alcohol dependence	0.00045	0.0186	CbGeAlD
Cevimeline—CHRM3—brain—alcohol dependence	0.000402	0.0167	CbGeAlD
Cevimeline—CYP3A4—digestive system—alcohol dependence	0.000374	0.0155	CbGeAlD
Cevimeline—CYP2D6—digestive system—alcohol dependence	0.000368	0.0153	CbGeAlD
Cevimeline—CYP3A4—blood—alcohol dependence	0.000356	0.0148	CbGeAlD
Cevimeline—CYP2D6—blood—alcohol dependence	0.000351	0.0145	CbGeAlD
Cevimeline—Tinnitus—Acamprosate—alcohol dependence	0.000313	0.000869	CcSEcCtD
Cevimeline—Hot flush—Citalopram—alcohol dependence	0.000311	0.000864	CcSEcCtD
Cevimeline—Amnesia—Citalopram—alcohol dependence	0.00031	0.00086	CcSEcCtD
Cevimeline—Increased appetite—Citalopram—alcohol dependence	0.00031	0.00086	CcSEcCtD
Cevimeline—CYP3A4—endocrine gland—alcohol dependence	0.000309	0.0128	CbGeAlD
Cevimeline—Menopausal symptoms—Citalopram—alcohol dependence	0.000308	0.000856	CcSEcCtD
Cevimeline—Thirst—Citalopram—alcohol dependence	0.000306	0.000849	CcSEcCtD
Cevimeline—Rash—Disulfiram—alcohol dependence	0.000305	0.000848	CcSEcCtD
Cevimeline—Dermatitis bullous—Citalopram—alcohol dependence	0.000304	0.000845	CcSEcCtD
Cevimeline—CYP2D6—endocrine gland—alcohol dependence	0.000304	0.0126	CbGeAlD
Cevimeline—Headache—Disulfiram—alcohol dependence	0.000303	0.000842	CcSEcCtD
Cevimeline—Purpura—Citalopram—alcohol dependence	0.000302	0.000838	CcSEcCtD
Cevimeline—Chills—Acamprosate—alcohol dependence	0.000301	0.000836	CcSEcCtD
Cevimeline—Arthritis—Citalopram—alcohol dependence	0.000299	0.000831	CcSEcCtD
Cevimeline—Hypoglycaemia—Citalopram—alcohol dependence	0.000298	0.000828	CcSEcCtD
Cevimeline—Eye disorder—Naltrexone—alcohol dependence	0.000297	0.000824	CcSEcCtD
Cevimeline—Alopecia—Acamprosate—alcohol dependence	0.000297	0.000824	CcSEcCtD
Cevimeline—Tinnitus—Naltrexone—alcohol dependence	0.000296	0.000822	CcSEcCtD
Cevimeline—Cardiac disorder—Naltrexone—alcohol dependence	0.000295	0.000819	CcSEcCtD
Cevimeline—Malnutrition—Acamprosate—alcohol dependence	0.000292	0.000812	CcSEcCtD
Cevimeline—Hyponatraemia—Citalopram—alcohol dependence	0.000292	0.000811	CcSEcCtD
Cevimeline—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.000291	0.000808	CcSEcCtD
Cevimeline—Pain in extremity—Citalopram—alcohol dependence	0.000291	0.000808	CcSEcCtD
Cevimeline—Diplopia—Citalopram—alcohol dependence	0.000291	0.000808	CcSEcCtD
Cevimeline—Osteoarthritis—Citalopram—alcohol dependence	0.000291	0.000808	CcSEcCtD
Cevimeline—CYP2D6—testis—alcohol dependence	0.00029	0.012	CbGeAlD
Cevimeline—CYP3A4—nervous system—alcohol dependence	0.000289	0.012	CbGeAlD
Cevimeline—Angiopathy—Naltrexone—alcohol dependence	0.000288	0.0008	CcSEcCtD
Cevimeline—Flatulence—Acamprosate—alcohol dependence	0.000288	0.0008	CcSEcCtD
Cevimeline—Migraine—Citalopram—alcohol dependence	0.000286	0.000795	CcSEcCtD
Cevimeline—Affect lability—Citalopram—alcohol dependence	0.000286	0.000795	CcSEcCtD
Cevimeline—Dysgeusia—Acamprosate—alcohol dependence	0.000286	0.000795	CcSEcCtD
Cevimeline—Chills—Naltrexone—alcohol dependence	0.000285	0.000791	CcSEcCtD
Cevimeline—CYP2D6—nervous system—alcohol dependence	0.000285	0.0118	CbGeAlD
Cevimeline—Back pain—Acamprosate—alcohol dependence	0.000283	0.000785	CcSEcCtD
Cevimeline—Muscle spasms—Acamprosate—alcohol dependence	0.000281	0.00078	CcSEcCtD
Cevimeline—Face oedema—Citalopram—alcohol dependence	0.000281	0.00078	CcSEcCtD
Cevimeline—Alopecia—Naltrexone—alcohol dependence	0.000281	0.000779	CcSEcCtD
Cevimeline—CYP3A4—liver—alcohol dependence	0.000279	0.0116	CbGeAlD
Cevimeline—CYP3A4—central nervous system—alcohol dependence	0.000279	0.0115	CbGeAlD
Cevimeline—Urinary retention—Citalopram—alcohol dependence	0.000277	0.000768	CcSEcCtD
Cevimeline—Malnutrition—Naltrexone—alcohol dependence	0.000276	0.000768	CcSEcCtD
Cevimeline—Mood swings—Citalopram—alcohol dependence	0.000275	0.000765	CcSEcCtD
Cevimeline—CYP2D6—liver—alcohol dependence	0.000274	0.0114	CbGeAlD
Cevimeline—CYP2D6—central nervous system—alcohol dependence	0.000274	0.0114	CbGeAlD
Cevimeline—Tremor—Acamprosate—alcohol dependence	0.000274	0.00076	CcSEcCtD
Cevimeline—Flatulence—Naltrexone—alcohol dependence	0.000272	0.000757	CcSEcCtD
Cevimeline—Ill-defined disorder—Acamprosate—alcohol dependence	0.000271	0.000753	CcSEcCtD
Cevimeline—Dysgeusia—Naltrexone—alcohol dependence	0.000271	0.000752	CcSEcCtD
Cevimeline—Dehydration—Citalopram—alcohol dependence	0.00027	0.000751	CcSEcCtD
Cevimeline—Anaemia—Acamprosate—alcohol dependence	0.00027	0.00075	CcSEcCtD
Cevimeline—Agitation—Acamprosate—alcohol dependence	0.000268	0.000746	CcSEcCtD
Cevimeline—CYP2D6—cerebellum—alcohol dependence	0.000268	0.0111	CbGeAlD
Cevimeline—Back pain—Naltrexone—alcohol dependence	0.000267	0.000743	CcSEcCtD
Cevimeline—Dry skin—Citalopram—alcohol dependence	0.000267	0.00074	CcSEcCtD
Cevimeline—Muscle spasms—Naltrexone—alcohol dependence	0.000266	0.000738	CcSEcCtD
Cevimeline—Orthostatic hypotension—Citalopram—alcohol dependence	0.000266	0.000738	CcSEcCtD
Cevimeline—Hypokalaemia—Citalopram—alcohol dependence	0.000265	0.000735	CcSEcCtD
Cevimeline—Malaise—Acamprosate—alcohol dependence	0.000263	0.000732	CcSEcCtD
Cevimeline—Vertigo—Acamprosate—alcohol dependence	0.000262	0.000729	CcSEcCtD
Cevimeline—Syncope—Acamprosate—alcohol dependence	0.000262	0.000728	CcSEcCtD
Cevimeline—Leukopenia—Acamprosate—alcohol dependence	0.000261	0.000726	CcSEcCtD
Cevimeline—Tremor—Naltrexone—alcohol dependence	0.000259	0.000719	CcSEcCtD
Cevimeline—Palpitations—Acamprosate—alcohol dependence	0.000258	0.000717	CcSEcCtD
Cevimeline—Gastritis—Citalopram—alcohol dependence	0.000257	0.000715	CcSEcCtD
Cevimeline—Loss of consciousness—Acamprosate—alcohol dependence	0.000257	0.000713	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000256	0.000713	CcSEcCtD
Cevimeline—Muscular weakness—Citalopram—alcohol dependence	0.000256	0.000713	CcSEcCtD
Cevimeline—Ill-defined disorder—Naltrexone—alcohol dependence	0.000256	0.000712	CcSEcCtD
Cevimeline—Cough—Acamprosate—alcohol dependence	0.000255	0.000708	CcSEcCtD
Cevimeline—Agitation—Naltrexone—alcohol dependence	0.000254	0.000706	CcSEcCtD
Cevimeline—Convulsion—Acamprosate—alcohol dependence	0.000253	0.000703	CcSEcCtD
Cevimeline—Abdominal distension—Citalopram—alcohol dependence	0.000253	0.000703	CcSEcCtD
Cevimeline—Hypertension—Acamprosate—alcohol dependence	0.000252	0.000701	CcSEcCtD
Cevimeline—Asthma—Citalopram—alcohol dependence	0.000251	0.000698	CcSEcCtD
Cevimeline—Dysphagia—Citalopram—alcohol dependence	0.000251	0.000698	CcSEcCtD
Cevimeline—Malaise—Naltrexone—alcohol dependence	0.000249	0.000692	CcSEcCtD
Cevimeline—Eosinophilia—Citalopram—alcohol dependence	0.000249	0.000691	CcSEcCtD
Cevimeline—Arthralgia—Acamprosate—alcohol dependence	0.000249	0.000691	CcSEcCtD
Cevimeline—Myalgia—Acamprosate—alcohol dependence	0.000249	0.000691	CcSEcCtD
Cevimeline—Chest pain—Acamprosate—alcohol dependence	0.000249	0.000691	CcSEcCtD
Cevimeline—Syncope—Naltrexone—alcohol dependence	0.000248	0.000689	CcSEcCtD
Cevimeline—Anxiety—Acamprosate—alcohol dependence	0.000248	0.000689	CcSEcCtD
Cevimeline—Bronchospasm—Citalopram—alcohol dependence	0.000247	0.000687	CcSEcCtD
Cevimeline—Discomfort—Acamprosate—alcohol dependence	0.000246	0.000683	CcSEcCtD
Cevimeline—Angina pectoris—Citalopram—alcohol dependence	0.000245	0.00068	CcSEcCtD
Cevimeline—Sweating increased—Citalopram—alcohol dependence	0.000245	0.00068	CcSEcCtD
Cevimeline—Palpitations—Naltrexone—alcohol dependence	0.000244	0.000679	CcSEcCtD
Cevimeline—Loss of consciousness—Naltrexone—alcohol dependence	0.000243	0.000675	CcSEcCtD
Cevimeline—Bronchitis—Citalopram—alcohol dependence	0.000242	0.000671	CcSEcCtD
Cevimeline—Cough—Naltrexone—alcohol dependence	0.000241	0.00067	CcSEcCtD
Cevimeline—Confusional state—Acamprosate—alcohol dependence	0.00024	0.000668	CcSEcCtD
Cevimeline—Convulsion—Naltrexone—alcohol dependence	0.000239	0.000665	CcSEcCtD
Cevimeline—Hypertension—Naltrexone—alcohol dependence	0.000239	0.000663	CcSEcCtD
Cevimeline—Infection—Acamprosate—alcohol dependence	0.000237	0.000658	CcSEcCtD
Cevimeline—Chest pain—Naltrexone—alcohol dependence	0.000235	0.000654	CcSEcCtD
Cevimeline—Arthralgia—Naltrexone—alcohol dependence	0.000235	0.000654	CcSEcCtD
Cevimeline—Myalgia—Naltrexone—alcohol dependence	0.000235	0.000654	CcSEcCtD
Cevimeline—Dysuria—Citalopram—alcohol dependence	0.000235	0.000653	CcSEcCtD
Cevimeline—Shock—Acamprosate—alcohol dependence	0.000235	0.000652	CcSEcCtD
Cevimeline—Anxiety—Naltrexone—alcohol dependence	0.000234	0.000651	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000234	0.000649	CcSEcCtD
Cevimeline—Thrombocytopenia—Acamprosate—alcohol dependence	0.000233	0.000648	CcSEcCtD
Cevimeline—Tachycardia—Acamprosate—alcohol dependence	0.000233	0.000646	CcSEcCtD
Cevimeline—Discomfort—Naltrexone—alcohol dependence	0.000232	0.000646	CcSEcCtD
Cevimeline—Pollakiuria—Citalopram—alcohol dependence	0.000232	0.000645	CcSEcCtD
Cevimeline—Skin disorder—Acamprosate—alcohol dependence	0.000232	0.000643	CcSEcCtD
Cevimeline—Erectile dysfunction—Citalopram—alcohol dependence	0.000231	0.000643	CcSEcCtD
Cevimeline—Hyperhidrosis—Acamprosate—alcohol dependence	0.00023	0.00064	CcSEcCtD
Cevimeline—Photosensitivity reaction—Citalopram—alcohol dependence	0.000229	0.000637	CcSEcCtD
Cevimeline—Weight increased—Citalopram—alcohol dependence	0.000229	0.000635	CcSEcCtD
Cevimeline—Confusional state—Naltrexone—alcohol dependence	0.000227	0.000632	CcSEcCtD
Cevimeline—Weight decreased—Citalopram—alcohol dependence	0.000227	0.000632	CcSEcCtD
Cevimeline—Anorexia—Acamprosate—alcohol dependence	0.000227	0.000631	CcSEcCtD
Cevimeline—Hyperglycaemia—Citalopram—alcohol dependence	0.000227	0.00063	CcSEcCtD
Cevimeline—Oedema—Naltrexone—alcohol dependence	0.000226	0.000627	CcSEcCtD
Cevimeline—Pneumonia—Citalopram—alcohol dependence	0.000225	0.000626	CcSEcCtD
Cevimeline—Infection—Naltrexone—alcohol dependence	0.000224	0.000623	CcSEcCtD
Cevimeline—Depression—Citalopram—alcohol dependence	0.000223	0.000621	CcSEcCtD
Cevimeline—Hypotension—Acamprosate—alcohol dependence	0.000223	0.000619	CcSEcCtD
Cevimeline—Shock—Naltrexone—alcohol dependence	0.000222	0.000617	CcSEcCtD
Cevimeline—Nervous system disorder—Naltrexone—alcohol dependence	0.000221	0.000615	CcSEcCtD
Cevimeline—Acute coronary syndrome—Citalopram—alcohol dependence	0.000221	0.000614	CcSEcCtD
Cevimeline—Tachycardia—Naltrexone—alcohol dependence	0.00022	0.000612	CcSEcCtD
Cevimeline—Myocardial infarction—Citalopram—alcohol dependence	0.00022	0.00061	CcSEcCtD
Cevimeline—Neuropathy peripheral—Citalopram—alcohol dependence	0.00022	0.00061	CcSEcCtD
Cevimeline—Skin disorder—Naltrexone—alcohol dependence	0.000219	0.000609	CcSEcCtD
Cevimeline—Stomatitis—Citalopram—alcohol dependence	0.000218	0.000607	CcSEcCtD
Cevimeline—Hyperhidrosis—Naltrexone—alcohol dependence	0.000218	0.000606	CcSEcCtD
Cevimeline—Urinary tract infection—Citalopram—alcohol dependence	0.000218	0.000605	CcSEcCtD
Cevimeline—Conjunctivitis—Citalopram—alcohol dependence	0.000218	0.000605	CcSEcCtD
Cevimeline—CYP2D6—brain—alcohol dependence	0.000218	0.00902	CbGeAlD
Cevimeline—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000217	0.000603	CcSEcCtD
Cevimeline—Insomnia—Acamprosate—alcohol dependence	0.000216	0.000599	CcSEcCtD
Cevimeline—Anorexia—Naltrexone—alcohol dependence	0.000215	0.000597	CcSEcCtD
Cevimeline—Paraesthesia—Acamprosate—alcohol dependence	0.000214	0.000595	CcSEcCtD
Cevimeline—Haematuria—Citalopram—alcohol dependence	0.000214	0.000594	CcSEcCtD
Cevimeline—Dyspnoea—Acamprosate—alcohol dependence	0.000213	0.00059	CcSEcCtD
Cevimeline—Somnolence—Acamprosate—alcohol dependence	0.000212	0.000589	CcSEcCtD
Cevimeline—Epistaxis—Citalopram—alcohol dependence	0.000211	0.000587	CcSEcCtD
Cevimeline—Sinusitis—Citalopram—alcohol dependence	0.00021	0.000584	CcSEcCtD
Cevimeline—Dyspepsia—Acamprosate—alcohol dependence	0.00021	0.000583	CcSEcCtD
Cevimeline—Agranulocytosis—Citalopram—alcohol dependence	0.000209	0.000581	CcSEcCtD
Cevimeline—Decreased appetite—Acamprosate—alcohol dependence	0.000207	0.000576	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000206	0.000571	CcSEcCtD
Cevimeline—Insomnia—Naltrexone—alcohol dependence	0.000204	0.000567	CcSEcCtD
Cevimeline—Pain—Acamprosate—alcohol dependence	0.000204	0.000566	CcSEcCtD
Cevimeline—Constipation—Acamprosate—alcohol dependence	0.000204	0.000566	CcSEcCtD
Cevimeline—Paraesthesia—Naltrexone—alcohol dependence	0.000203	0.000563	CcSEcCtD
Cevimeline—Haemoglobin—Citalopram—alcohol dependence	0.000202	0.000562	CcSEcCtD
Cevimeline—Rhinitis—Citalopram—alcohol dependence	0.000202	0.00056	CcSEcCtD
Cevimeline—Haemorrhage—Citalopram—alcohol dependence	0.000201	0.000559	CcSEcCtD
Cevimeline—Dyspnoea—Naltrexone—alcohol dependence	0.000201	0.000559	CcSEcCtD
Cevimeline—Somnolence—Naltrexone—alcohol dependence	0.000201	0.000557	CcSEcCtD
Cevimeline—Hallucination—Citalopram—alcohol dependence	0.0002	0.000556	CcSEcCtD
Cevimeline—Hypoaesthesia—Citalopram—alcohol dependence	0.0002	0.000556	CcSEcCtD
Cevimeline—Pharyngitis—Citalopram—alcohol dependence	0.0002	0.000555	CcSEcCtD
Cevimeline—Oedema peripheral—Citalopram—alcohol dependence	0.000198	0.000551	CcSEcCtD
Cevimeline—Urethral disorder—Citalopram—alcohol dependence	0.000197	0.000548	CcSEcCtD
Cevimeline—Feeling abnormal—Acamprosate—alcohol dependence	0.000196	0.000546	CcSEcCtD
Cevimeline—Decreased appetite—Naltrexone—alcohol dependence	0.000196	0.000545	CcSEcCtD
Cevimeline—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000195	0.000542	CcSEcCtD
Cevimeline—Fatigue—Naltrexone—alcohol dependence	0.000194	0.00054	CcSEcCtD
Cevimeline—Visual impairment—Citalopram—alcohol dependence	0.000194	0.000539	CcSEcCtD
Cevimeline—Constipation—Naltrexone—alcohol dependence	0.000193	0.000536	CcSEcCtD
Cevimeline—Pain—Naltrexone—alcohol dependence	0.000193	0.000536	CcSEcCtD
Cevimeline—Urticaria—Acamprosate—alcohol dependence	0.000189	0.000526	CcSEcCtD
Cevimeline—Abdominal pain—Acamprosate—alcohol dependence	0.000188	0.000524	CcSEcCtD
Cevimeline—Body temperature increased—Acamprosate—alcohol dependence	0.000188	0.000524	CcSEcCtD
Cevimeline—Eye disorder—Citalopram—alcohol dependence	0.000188	0.000522	CcSEcCtD
Cevimeline—Tinnitus—Citalopram—alcohol dependence	0.000188	0.000521	CcSEcCtD
Cevimeline—Cardiac disorder—Citalopram—alcohol dependence	0.000187	0.000519	CcSEcCtD
Cevimeline—Flushing—Citalopram—alcohol dependence	0.000187	0.000519	CcSEcCtD
Cevimeline—Feeling abnormal—Naltrexone—alcohol dependence	0.000186	0.000516	CcSEcCtD
Cevimeline—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000184	0.000512	CcSEcCtD
Cevimeline—Angiopathy—Citalopram—alcohol dependence	0.000183	0.000507	CcSEcCtD
Cevimeline—Chills—Citalopram—alcohol dependence	0.000181	0.000501	CcSEcCtD
Cevimeline—Arrhythmia—Citalopram—alcohol dependence	0.00018	0.000499	CcSEcCtD
Cevimeline—Urticaria—Naltrexone—alcohol dependence	0.000179	0.000498	CcSEcCtD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.000179	0.00119	CbGpPWpGaD
Cevimeline—Abdominal pain—Naltrexone—alcohol dependence	0.000178	0.000495	CcSEcCtD
Cevimeline—Body temperature increased—Naltrexone—alcohol dependence	0.000178	0.000495	CcSEcCtD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.000178	0.00118	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—DRD2—alcohol dependence	0.000178	0.00118	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—HTR7—alcohol dependence	0.000178	0.00118	CbGpPWpGaD
Cevimeline—Alopecia—Citalopram—alcohol dependence	0.000178	0.000494	CcSEcCtD
Cevimeline—Hypersensitivity—Acamprosate—alcohol dependence	0.000176	0.000488	CcSEcCtD
Cevimeline—Malnutrition—Citalopram—alcohol dependence	0.000175	0.000487	CcSEcCtD
Cevimeline—Flatulence—Citalopram—alcohol dependence	0.000173	0.000479	CcSEcCtD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.000173	0.00114	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.000172	0.00114	CbGpPWpGaD
Cevimeline—Dysgeusia—Citalopram—alcohol dependence	0.000171	0.000476	CcSEcCtD
Cevimeline—Asthenia—Acamprosate—alcohol dependence	0.000171	0.000475	CcSEcCtD
Cevimeline—CHRM1—GPCR ligand binding—OPRD1—alcohol dependence	0.000171	0.00113	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—OPRD1—alcohol dependence	0.00017	0.00113	CbGpPWpGaD
Cevimeline—Back pain—Citalopram—alcohol dependence	0.000169	0.000471	CcSEcCtD
Cevimeline—Pruritus—Acamprosate—alcohol dependence	0.000169	0.000469	CcSEcCtD
Cevimeline—Muscle spasms—Citalopram—alcohol dependence	0.000168	0.000468	CcSEcCtD
Cevimeline—Hypersensitivity—Naltrexone—alcohol dependence	0.000166	0.000462	CcSEcCtD
Cevimeline—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000166	0.0011	CbGpPWpGaD
Cevimeline—Tremor—Citalopram—alcohol dependence	0.000164	0.000456	CcSEcCtD
Cevimeline—CHRM1—GPCR ligand binding—PDYN—alcohol dependence	0.000164	0.00109	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—PDYN—alcohol dependence	0.000163	0.00108	CbGpPWpGaD
Cevimeline—Diarrhoea—Acamprosate—alcohol dependence	0.000163	0.000453	CcSEcCtD
Cevimeline—Ill-defined disorder—Citalopram—alcohol dependence	0.000162	0.000451	CcSEcCtD
Cevimeline—Anaemia—Citalopram—alcohol dependence	0.000162	0.00045	CcSEcCtD
Cevimeline—Asthenia—Naltrexone—alcohol dependence	0.000162	0.00045	CcSEcCtD
Cevimeline—Agitation—Citalopram—alcohol dependence	0.000161	0.000447	CcSEcCtD
Cevimeline—Pruritus—Naltrexone—alcohol dependence	0.00016	0.000443	CcSEcCtD
Cevimeline—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000159	0.00105	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.000159	0.00105	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—AVP—alcohol dependence	0.000159	0.00105	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.000158	0.00105	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—AVP—alcohol dependence	0.000158	0.00105	CbGpPWpGaD
Cevimeline—Malaise—Citalopram—alcohol dependence	0.000158	0.000439	CcSEcCtD
Cevimeline—Dizziness—Acamprosate—alcohol dependence	0.000158	0.000438	CcSEcCtD
Cevimeline—Vertigo—Citalopram—alcohol dependence	0.000157	0.000437	CcSEcCtD
Cevimeline—Syncope—Citalopram—alcohol dependence	0.000157	0.000436	CcSEcCtD
Cevimeline—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	0.000157	0.00104	CbGpPWpGaD
Cevimeline—Leukopenia—Citalopram—alcohol dependence	0.000157	0.000435	CcSEcCtD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.000156	0.00104	CbGpPWpGaD
Cevimeline—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000156	0.00103	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.000156	0.00103	CbGpPWpGaD
Cevimeline—Palpitations—Citalopram—alcohol dependence	0.000155	0.00043	CcSEcCtD
Cevimeline—Diarrhoea—Naltrexone—alcohol dependence	0.000154	0.000429	CcSEcCtD
Cevimeline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000154	0.00102	CbGpPWpGaD
Cevimeline—Loss of consciousness—Citalopram—alcohol dependence	0.000154	0.000428	CcSEcCtD
Cevimeline—FMO1—Metabolism—GOT2—alcohol dependence	0.000153	0.00102	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.000153	0.00102	CbGpPWpGaD
Cevimeline—Cough—Citalopram—alcohol dependence	0.000153	0.000425	CcSEcCtD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.000153	0.00101	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CRHR1—alcohol dependence	0.000152	0.00101	CbGpPWpGaD
Cevimeline—Convulsion—Citalopram—alcohol dependence	0.000152	0.000422	CcSEcCtD
Cevimeline—CHRM3—GPCR ligand binding—CRHR1—alcohol dependence	0.000152	0.00101	CbGpPWpGaD
Cevimeline—Vomiting—Acamprosate—alcohol dependence	0.000152	0.000421	CcSEcCtD
Cevimeline—Hypertension—Citalopram—alcohol dependence	0.000151	0.00042	CcSEcCtD
Cevimeline—Rash—Acamprosate—alcohol dependence	0.00015	0.000418	CcSEcCtD
Cevimeline—Dermatitis—Acamprosate—alcohol dependence	0.00015	0.000417	CcSEcCtD
Cevimeline—CHRM1—Circadian rythm related genes—AVP—alcohol dependence	0.00015	0.000992	CbGpPWpGaD
Cevimeline—Headache—Acamprosate—alcohol dependence	0.000149	0.000415	CcSEcCtD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.000149	0.000989	CbGpPWpGaD
Cevimeline—Dizziness—Naltrexone—alcohol dependence	0.000149	0.000414	CcSEcCtD
Cevimeline—Chest pain—Citalopram—alcohol dependence	0.000149	0.000414	CcSEcCtD
Cevimeline—Arthralgia—Citalopram—alcohol dependence	0.000149	0.000414	CcSEcCtD
Cevimeline—Myalgia—Citalopram—alcohol dependence	0.000149	0.000414	CcSEcCtD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.000149	0.000986	CbGpPWpGaD
Cevimeline—Anxiety—Citalopram—alcohol dependence	0.000149	0.000413	CcSEcCtD
Cevimeline—Discomfort—Citalopram—alcohol dependence	0.000147	0.000409	CcSEcCtD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.000146	0.000965	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.000146	0.000965	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000145	0.000964	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.000145	0.000962	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.000145	0.000962	CbGpPWpGaD
Cevimeline—Confusional state—Citalopram—alcohol dependence	0.000144	0.0004	CcSEcCtD
Cevimeline—FMO1—Metabolism—CYP2E1—alcohol dependence	0.000144	0.000955	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—OPRK1—alcohol dependence	0.000144	0.000952	CbGpPWpGaD
Cevimeline—Vomiting—Naltrexone—alcohol dependence	0.000143	0.000398	CcSEcCtD
Cevimeline—CHRM3—GPCR downstream signaling—OPRK1—alcohol dependence	0.000143	0.000949	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CHRM2—alcohol dependence	0.000143	0.000948	CbGpPWpGaD
Cevimeline—Oedema—Citalopram—alcohol dependence	0.000143	0.000397	CcSEcCtD
Cevimeline—CHRM3—GPCR ligand binding—CHRM2—alcohol dependence	0.000143	0.000945	CbGpPWpGaD
Cevimeline—Rash—Naltrexone—alcohol dependence	0.000142	0.000395	CcSEcCtD
Cevimeline—Dermatitis—Naltrexone—alcohol dependence	0.000142	0.000395	CcSEcCtD
Cevimeline—Infection—Citalopram—alcohol dependence	0.000142	0.000394	CcSEcCtD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.000142	0.00094	CbGpPWpGaD
Cevimeline—Nausea—Acamprosate—alcohol dependence	0.000142	0.000393	CcSEcCtD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.000141	0.000937	CbGpPWpGaD
Cevimeline—Headache—Naltrexone—alcohol dependence	0.000141	0.000393	CcSEcCtD
Cevimeline—Shock—Citalopram—alcohol dependence	0.000141	0.000391	CcSEcCtD
Cevimeline—Nervous system disorder—Citalopram—alcohol dependence	0.00014	0.000389	CcSEcCtD
Cevimeline—Thrombocytopenia—Citalopram—alcohol dependence	0.00014	0.000389	CcSEcCtD
Cevimeline—Tachycardia—Citalopram—alcohol dependence	0.000139	0.000388	CcSEcCtD
Cevimeline—Skin disorder—Citalopram—alcohol dependence	0.000139	0.000386	CcSEcCtD
Cevimeline—Hyperhidrosis—Citalopram—alcohol dependence	0.000138	0.000384	CcSEcCtD
Cevimeline—Anorexia—Citalopram—alcohol dependence	0.000136	0.000378	CcSEcCtD
Cevimeline—Nausea—Naltrexone—alcohol dependence	0.000134	0.000372	CcSEcCtD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000134	0.000887	CbGpPWpGaD
Cevimeline—Hypotension—Citalopram—alcohol dependence	0.000134	0.000371	CcSEcCtD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000133	0.000885	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—GOT1—alcohol dependence	0.000132	0.000877	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—GGT1—alcohol dependence	0.000132	0.000877	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—HTR2A—alcohol dependence	0.000132	0.000874	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—HTR2A—alcohol dependence	0.000132	0.000872	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—OPRM1—alcohol dependence	0.000131	0.000871	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—OPRM1—alcohol dependence	0.000131	0.000868	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—OPRK1—alcohol dependence	0.00013	0.000864	CbGpPWpGaD
Cevimeline—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00013	0.000362	CcSEcCtD
Cevimeline—CHRM3—Signaling by GPCR—OPRK1—alcohol dependence	0.00013	0.000861	CbGpPWpGaD
Cevimeline—Insomnia—Citalopram—alcohol dependence	0.000129	0.000359	CcSEcCtD
Cevimeline—Paraesthesia—Citalopram—alcohol dependence	0.000128	0.000357	CcSEcCtD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000128	0.000847	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000127	0.000845	CbGpPWpGaD
Cevimeline—Dyspnoea—Citalopram—alcohol dependence	0.000127	0.000354	CcSEcCtD
Cevimeline—Somnolence—Citalopram—alcohol dependence	0.000127	0.000353	CcSEcCtD
Cevimeline—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000127	0.000841	CbGpPWpGaD
Cevimeline—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000126	0.000838	CbGpPWpGaD
Cevimeline—Dyspepsia—Citalopram—alcohol dependence	0.000126	0.00035	CcSEcCtD
Cevimeline—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	0.000125	0.000831	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000125	0.000827	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000125	0.000827	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000124	0.000824	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000124	0.000824	CbGpPWpGaD
Cevimeline—Decreased appetite—Citalopram—alcohol dependence	0.000124	0.000345	CcSEcCtD
Cevimeline—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000124	0.000819	CbGpPWpGaD
Cevimeline—Fatigue—Citalopram—alcohol dependence	0.000123	0.000342	CcSEcCtD
Cevimeline—Constipation—Citalopram—alcohol dependence	0.000122	0.00034	CcSEcCtD
Cevimeline—Pain—Citalopram—alcohol dependence	0.000122	0.00034	CcSEcCtD
Cevimeline—CHRM3—Metabolism—ADH6—alcohol dependence	0.000121	0.000803	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—NPY—alcohol dependence	0.000121	0.000801	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000121	0.000799	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—NPY—alcohol dependence	0.000121	0.000799	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—MAOA—alcohol dependence	0.000119	0.000786	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.000118	0.000782	CbGpPWpGaD
Cevimeline—Feeling abnormal—Citalopram—alcohol dependence	0.000118	0.000327	CcSEcCtD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.000118	0.000779	CbGpPWpGaD
Cevimeline—Gastrointestinal pain—Citalopram—alcohol dependence	0.000117	0.000325	CcSEcCtD
Cevimeline—CHRM1—GPCR ligand binding—HTR1B—alcohol dependence	0.000117	0.000773	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CRH—alcohol dependence	0.000117	0.000773	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR1B—alcohol dependence	0.000116	0.000771	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CRH—alcohol dependence	0.000116	0.000771	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—GGT1—alcohol dependence	0.000115	0.000763	CbGpPWpGaD
Cevimeline—Urticaria—Citalopram—alcohol dependence	0.000114	0.000315	CcSEcCtD
Cevimeline—Body temperature increased—Citalopram—alcohol dependence	0.000113	0.000314	CcSEcCtD
Cevimeline—Abdominal pain—Citalopram—alcohol dependence	0.000113	0.000314	CcSEcCtD
Cevimeline—Hypersensitivity—Citalopram—alcohol dependence	0.000105	0.000293	CcSEcCtD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000105	0.000696	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000105	0.000694	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—MAOA—alcohol dependence	0.000103	0.000683	CbGpPWpGaD
Cevimeline—Asthenia—Citalopram—alcohol dependence	0.000103	0.000285	CcSEcCtD
Cevimeline—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000103	0.000679	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000102	0.000676	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—DRD4—alcohol dependence	0.000102	0.000676	CbGpPWpGaD
Cevimeline—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000102	0.000676	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000102	0.000674	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—DRD4—alcohol dependence	0.000102	0.000674	CbGpPWpGaD
Cevimeline—Pruritus—Citalopram—alcohol dependence	0.000101	0.000281	CcSEcCtD
Cevimeline—CHRM3—Metabolism—ADH1A—alcohol dependence	0.0001	0.000665	CbGpPWpGaD
Cevimeline—Diarrhoea—Citalopram—alcohol dependence	9.78e-05	0.000272	CcSEcCtD
Cevimeline—CHRM1—GPCR ligand binding—CNR1—alcohol dependence	9.74e-05	0.000645	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CNR1—alcohol dependence	9.71e-05	0.000643	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—OPRD1—alcohol dependence	9.65e-05	0.00064	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—OPRD1—alcohol dependence	9.62e-05	0.000638	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—DRD2—alcohol dependence	9.5e-05	0.00063	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HTR7—alcohol dependence	9.5e-05	0.00063	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR7—alcohol dependence	9.47e-05	0.000628	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—DRD2—alcohol dependence	9.47e-05	0.000628	CbGpPWpGaD
Cevimeline—Dizziness—Citalopram—alcohol dependence	9.45e-05	0.000263	CcSEcCtD
Cevimeline—CHRM1—GPCR downstream signaling—PDYN—alcohol dependence	9.25e-05	0.000613	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PDYN—alcohol dependence	9.22e-05	0.000611	CbGpPWpGaD
Cevimeline—Vomiting—Citalopram—alcohol dependence	9.09e-05	0.000252	CcSEcCtD
Cevimeline—Rash—Citalopram—alcohol dependence	9.01e-05	0.00025	CcSEcCtD
Cevimeline—Dermatitis—Citalopram—alcohol dependence	9e-05	0.00025	CcSEcCtD
Cevimeline—Headache—Citalopram—alcohol dependence	8.95e-05	0.000249	CcSEcCtD
Cevimeline—CHRM1—Signaling by GPCR—OPRD1—alcohol dependence	8.76e-05	0.000581	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	8.74e-05	0.000579	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—OPRD1—alcohol dependence	8.74e-05	0.000579	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	8.71e-05	0.000577	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CRHR1—alcohol dependence	8.6e-05	0.00057	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CRHR1—alcohol dependence	8.57e-05	0.000568	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ADH4—alcohol dependence	8.54e-05	0.000566	CbGpPWpGaD
Cevimeline—Nausea—Citalopram—alcohol dependence	8.49e-05	0.000236	CcSEcCtD
Cevimeline—CHRM1—Signaling by GPCR—PDYN—alcohol dependence	8.4e-05	0.000557	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PDYN—alcohol dependence	8.38e-05	0.000555	CbGpPWpGaD
Cevimeline—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	8.26e-05	0.000548	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	8.19e-05	0.000543	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CHRM2—alcohol dependence	8.09e-05	0.000536	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	8.08e-05	0.000536	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CHRM2—alcohol dependence	8.06e-05	0.000534	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—AVP—alcohol dependence	8e-05	0.00053	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—AVP—alcohol dependence	7.97e-05	0.000528	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CRHR1—alcohol dependence	7.81e-05	0.000518	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CRHR1—alcohol dependence	7.79e-05	0.000516	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—POMC—alcohol dependence	7.72e-05	0.000512	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—OPRK1—alcohol dependence	7.7e-05	0.00051	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—OPRK1—alcohol dependence	7.68e-05	0.000509	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—GGT1—alcohol dependence	7.52e-05	0.000499	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—OPRM1—alcohol dependence	7.43e-05	0.000492	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—OPRM1—alcohol dependence	7.4e-05	0.000491	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CHRM2—alcohol dependence	7.34e-05	0.000487	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CHRM2—alcohol dependence	7.32e-05	0.000485	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ADH7—alcohol dependence	7.26e-05	0.000481	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ADH6—alcohol dependence	7.24e-05	0.00048	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	6.98e-05	0.000462	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GGT2—alcohol dependence	6.96e-05	0.000461	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	6.96e-05	0.000461	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—NPY—alcohol dependence	6.83e-05	0.000453	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—NPY—alcohol dependence	6.81e-05	0.000451	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—OPRM1—alcohol dependence	6.74e-05	0.000447	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—MAOA—alcohol dependence	6.74e-05	0.000447	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—OPRM1—alcohol dependence	6.72e-05	0.000445	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—POMC—alcohol dependence	6.71e-05	0.000445	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HTR2A—alcohol dependence	6.65e-05	0.000441	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR2A—alcohol dependence	6.63e-05	0.00044	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—EP300—alcohol dependence	6.6e-05	0.000437	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR1B—alcohol dependence	6.59e-05	0.000437	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CRH—alcohol dependence	6.59e-05	0.000437	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR1B—alcohol dependence	6.57e-05	0.000436	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CRH—alcohol dependence	6.57e-05	0.000436	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ADH1B—alcohol dependence	6.36e-05	0.000422	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—NPY—alcohol dependence	6.21e-05	0.000411	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—NPY—alcohol dependence	6.19e-05	0.00041	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ADH1A—alcohol dependence	6e-05	0.000398	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CRH—alcohol dependence	5.99e-05	0.000397	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR1B—alcohol dependence	5.99e-05	0.000397	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR1B—alcohol dependence	5.97e-05	0.000396	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CRH—alcohol dependence	5.97e-05	0.000396	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—DRD4—alcohol dependence	5.76e-05	0.000382	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—DRD4—alcohol dependence	5.74e-05	0.000381	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CNR1—alcohol dependence	5.5e-05	0.000365	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CNR1—alcohol dependence	5.48e-05	0.000364	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR7—alcohol dependence	5.37e-05	0.000356	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—DRD2—alcohol dependence	5.37e-05	0.000356	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—DRD2—alcohol dependence	5.35e-05	0.000355	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR7—alcohol dependence	5.35e-05	0.000355	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—POMC—alcohol dependence	5.31e-05	0.000352	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—POMC—alcohol dependence	5.3e-05	0.000351	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MAOB—alcohol dependence	5.27e-05	0.00035	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—DRD4—alcohol dependence	5.23e-05	0.000347	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—DRD4—alcohol dependence	5.22e-05	0.000346	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—OPRD1—alcohol dependence	5.18e-05	0.000343	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—OPRD1—alcohol dependence	5.16e-05	0.000342	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—EP300—alcohol dependence	5.12e-05	0.000339	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ADH4—alcohol dependence	5.1e-05	0.000338	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CNR1—alcohol dependence	5e-05	0.000331	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CNR1—alcohol dependence	4.98e-05	0.00033	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PDYN—alcohol dependence	4.96e-05	0.000329	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PDYN—alcohol dependence	4.95e-05	0.000328	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—DRD2—alcohol dependence	4.87e-05	0.000323	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR7—alcohol dependence	4.87e-05	0.000323	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR7—alcohol dependence	4.86e-05	0.000322	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—DRD2—alcohol dependence	4.86e-05	0.000322	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ADH6—alcohol dependence	4.74e-05	0.000314	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—WASF2—alcohol dependence	4.61e-05	0.000306	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CRHR1—alcohol dependence	4.61e-05	0.000306	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—WASF2—alcohol dependence	4.6e-05	0.000305	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CRHR1—alcohol dependence	4.6e-05	0.000305	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—AVP—alcohol dependence	4.52e-05	0.000299	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—AVP—alcohol dependence	4.5e-05	0.000299	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ALDH2—alcohol dependence	4.48e-05	0.000297	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—WASF1—alcohol dependence	4.42e-05	0.000293	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—WASF1—alcohol dependence	4.41e-05	0.000292	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—POMC—alcohol dependence	4.39e-05	0.000291	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ADH7—alcohol dependence	4.34e-05	0.000288	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CHRM2—alcohol dependence	4.34e-05	0.000288	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CHRM2—alcohol dependence	4.32e-05	0.000287	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GGT2—alcohol dependence	4.16e-05	0.000276	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—AVP—alcohol dependence	4.1e-05	0.000272	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AVP—alcohol dependence	4.09e-05	0.000271	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—OPRM1—alcohol dependence	3.98e-05	0.000264	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—OPRM1—alcohol dependence	3.97e-05	0.000263	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ADH1A—alcohol dependence	3.92e-05	0.00026	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GOT2—alcohol dependence	3.81e-05	0.000253	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ADH1B—alcohol dependence	3.81e-05	0.000252	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR2A—alcohol dependence	3.76e-05	0.000249	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR2A—alcohol dependence	3.75e-05	0.000248	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NPY—alcohol dependence	3.67e-05	0.000243	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NPY—alcohol dependence	3.65e-05	0.000242	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP2E1—alcohol dependence	3.58e-05	0.000238	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR1B—alcohol dependence	3.54e-05	0.000234	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CRH—alcohol dependence	3.54e-05	0.000234	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CRH—alcohol dependence	3.53e-05	0.000234	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR1B—alcohol dependence	3.53e-05	0.000234	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR2A—alcohol dependence	3.41e-05	0.000226	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR2A—alcohol dependence	3.4e-05	0.000226	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ADH4—alcohol dependence	3.34e-05	0.000221	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GOT1—alcohol dependence	3.29e-05	0.000218	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GGT1—alcohol dependence	3.29e-05	0.000218	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MAOB—alcohol dependence	3.15e-05	0.000209	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DRD4—alcohol dependence	3.09e-05	0.000205	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DRD4—alcohol dependence	3.08e-05	0.000204	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—POMC—alcohol dependence	3e-05	0.000199	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—POMC—alcohol dependence	2.99e-05	0.000198	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CNR1—alcohol dependence	2.95e-05	0.000196	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MAOA—alcohol dependence	2.95e-05	0.000195	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CNR1—alcohol dependence	2.94e-05	0.000195	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR7—alcohol dependence	2.88e-05	0.000191	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DRD2—alcohol dependence	2.88e-05	0.000191	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DRD2—alcohol dependence	2.87e-05	0.00019	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR7—alcohol dependence	2.87e-05	0.00019	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ADH7—alcohol dependence	2.84e-05	0.000188	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—POMC—alcohol dependence	2.73e-05	0.000181	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GGT2—alcohol dependence	2.72e-05	0.00018	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—POMC—alcohol dependence	2.72e-05	0.00018	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALDH2—alcohol dependence	2.68e-05	0.000178	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ADH1B—alcohol dependence	2.49e-05	0.000165	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AVP—alcohol dependence	2.42e-05	0.000161	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AVP—alcohol dependence	2.42e-05	0.00016	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GOT2—alcohol dependence	2.28e-05	0.000151	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP2E1—alcohol dependence	2.14e-05	0.000142	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MAOB—alcohol dependence	2.06e-05	0.000137	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR2A—alcohol dependence	2.02e-05	0.000134	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR2A—alcohol dependence	2.01e-05	0.000133	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GGT1—alcohol dependence	1.97e-05	0.00013	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GOT1—alcohol dependence	1.97e-05	0.00013	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—POMC—alcohol dependence	1.92e-05	0.000127	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MAOA—alcohol dependence	1.76e-05	0.000117	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.75e-05	0.000116	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—POMC—alcohol dependence	1.61e-05	0.000107	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—POMC—alcohol dependence	1.61e-05	0.000106	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GOT2—alcohol dependence	1.49e-05	9.88e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.4e-05	9.29e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GGT1—alcohol dependence	1.29e-05	8.53e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GOT1—alcohol dependence	1.29e-05	8.53e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—EP300—alcohol dependence	1.27e-05	8.44e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MAOA—alcohol dependence	1.15e-05	7.64e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—POMC—alcohol dependence	1.15e-05	7.61e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EP300—alcohol dependence	1.07e-05	7.08e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EP300—alcohol dependence	1.07e-05	7.06e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—EP300—alcohol dependence	7.62e-06	5.05e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—POMC—alcohol dependence	7.51e-06	4.98e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—EP300—alcohol dependence	4.98e-06	3.3e-05	CbGpPWpGaD
